Aligned Genetics Inc (238120) — Capital Reinvestment Ratio
Aligned Genetics Inc (238120) has a Capital Reinvestment Ratio of 0.24x as of June 2025, meaning it reinvests 0% of its operating cash flow (₩677.20 Million) in capital expenditures (₩165.20 Million). See Aligned Genetics Inc balance sheet independence to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Aligned Genetics Inc Capital Reinvestment Ratio (2019–2024)
This chart tracks Aligned Genetics Inc's Capital Reinvestment Ratio across 6 annual periods. Check how aggressively does Aligned Genetics Inc reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Aligned Genetics Inc (2019–2024)
Year-by-year Capital Reinvestment Ratio for Aligned Genetics Inc from 2019 to 2024. For live market cap and broader valuation context, see Aligned Genetics Inc (238120) total market value.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.11x | ₩3.07 Billion | ₩340.06 Million | ▼ -64.1% |
| 2023 | 0.31x | ₩2.85 Billion | ₩880.42 Million | ▼ -65.7% |
| 2022 | 0.90x | ₩2.22 Billion | ₩2.00 Billion | ▼ -96.3% |
| 2021 | 24.33x | ₩135.97 Million | ₩3.31 Billion | ▲ +799.8% |
| 2020 | 2.70x | ₩35.67 Million | ₩96.43 Million | ▲ +581.3% |
| 2019 | 0.40x | ₩659.29 Million | ₩261.62 Million | — |